You are here

  • Home
  • Online First
  • White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)

Article info

Article menu
Download PDFPDF
Neurodegeneration
Short report
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)

Authors

  • Nurit Omer Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Labratory for early markers of neurodegeneration, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Amgad Droby Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Labratory for early markers of neurodegeneration, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Rawan Silbak Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Noa Trablus Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Aya Bar David Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Tamara Shiner Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Yifat Alcalay Encephalitis Center and Immunology Laboratory, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Roy Alcalay Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel Genetic labratory for neurodegeration, Tel Aviv Ichilov-Sourasky Medical Center, Tel-Aviv, Israel PubMed articlesGoogle scholar articles
  • Talya Nathan Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Avner Thaler Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Labratory for early markers of neurodegeneration, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Anat Mirelman Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Labratory for early markers of neurodegeneration, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Mali Gana Weisz Genetic labratory for neurodegeration, Tel Aviv Ichilov-Sourasky Medical Center, Tel-Aviv, Israel PubMed articlesGoogle scholar articles
  • Orly Goldstein Genetic labratory for neurodegeration, Tel Aviv Ichilov-Sourasky Medical Center, Tel-Aviv, Israel PubMed articlesGoogle scholar articles
  • Tal Glinka Genetic labratory for neurodegeration, Tel Aviv Ichilov-Sourasky Medical Center, Tel-Aviv, Israel PubMed articlesGoogle scholar articles
  • Avi Orr-Urtreger Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Genetic Institute, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Nir Giladi Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Noa Bregman Neurology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Faculty of Medical and Health Sciences, Tel Aviv Universty, Tel Aviv, Israel Cognitive Neurology Unit, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nurit Omer; nurito{at}tlvmc.gov.il
View Full Text

Citation

Omer N, Droby A, Silbak R, et al
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)
Journal of Neurology, Neurosurgery & Psychiatry Published Online First: 30 July 2024. doi: 10.1136/jnnp-2024-333751

Publication history

  • Received March 10, 2024
  • Accepted July 11, 2024
  • First published July 30, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.